載入...
The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT(6) Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment
Among serotonin receptors, the 5-HT(6) subtype is the most controversial and the least known in the field of molecular mechanisms. The 5-HT(6)R ligands can be pivotal for innovative treatment of cognitive impairment, but none has reached pharmacological market, predominantly, due to insufficient “dr...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6678253/ https://ncbi.nlm.nih.gov/pubmed/31336820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20143420 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|